Moelis & Company (NYSE:MC – Free Report) – Equities research analysts at Zacks Research cut their Q2 2026 earnings estimates for shares of Moelis & Company in a note issued to investors on Wednesday, May 14th. Zacks Research analyst R. Department now expects that the asset manager will post earnings of $0.55 per share for the quarter, down from their previous forecast of $0.70. The consensus estimate for Moelis & Company’s current full-year earnings is $2.97 per share. Zacks Research also issued estimates for Moelis & Company’s Q3 2026 earnings at $0.61 EPS, Q1 2027 earnings at $0.77 EPS and FY2027 earnings at $3.51 EPS.
Other research analysts have also recently issued research reports about the stock. JPMorgan Chase & Co. decreased their price objective on shares of Moelis & Company from $55.00 to $52.00 and set a “neutral” rating for the company in a report on Thursday, April 24th. The Goldman Sachs Group boosted their price objective on shares of Moelis & Company from $56.00 to $63.00 and gave the company a “neutral” rating in a report on Thursday. StockNews.com cut shares of Moelis & Company from a “buy” rating to a “hold” rating in a report on Thursday, March 13th. JMP Securities restated a “market perform” rating on shares of Moelis & Company in a report on Thursday, April 24th. Finally, Wells Fargo & Company decreased their price objective on shares of Moelis & Company from $55.00 to $50.00 and set an “equal weight” rating for the company in a report on Thursday, April 24th. Two investment analysts have rated the stock with a sell rating, five have issued a hold rating and one has assigned a buy rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus target price of $59.83.
Moelis & Company Stock Performance
Shares of NYSE MC opened at $61.61 on Thursday. The stock has a market cap of $4.84 billion, a P/E ratio of 35.00 and a beta of 1.66. The firm has a 50 day moving average price of $55.63 and a 200 day moving average price of $67.68. Moelis & Company has a 52-week low of $47.00 and a 52-week high of $82.89.
Moelis & Company (NYSE:MC – Get Free Report) last issued its quarterly earnings results on Wednesday, April 23rd. The asset manager reported $0.64 EPS for the quarter, topping the consensus estimate of $0.57 by $0.07. The company had revenue of $306.59 million during the quarter, compared to analysts’ expectations of $309.67 million. Moelis & Company had a net margin of 11.39% and a return on equity of 38.49%. Moelis & Company’s revenue was up 41.0% on a year-over-year basis. During the same quarter in the previous year, the company earned $0.22 EPS.
Moelis & Company Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Friday, June 20th. Stockholders of record on Monday, May 5th will be issued a $0.65 dividend. This represents a $2.60 annualized dividend and a dividend yield of 4.22%. The ex-dividend date of this dividend is Monday, May 5th. Moelis & Company’s dividend payout ratio (DPR) is presently 119.27%.
Insider Activity
In other news, insider Christopher Callesano sold 1,282 shares of the business’s stock in a transaction on Wednesday, February 19th. The shares were sold at an average price of $74.00, for a total value of $94,868.00. Following the sale, the insider now owns 1,227 shares of the company’s stock, valued at $90,798. The trade was a 51.10% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Kenneth Shropshire sold 2,551 shares of the business’s stock in a transaction on Friday, February 21st. The stock was sold at an average price of $72.30, for a total transaction of $184,437.30. Following the completion of the sale, the director now directly owns 6,940 shares in the company, valued at approximately $501,762. This represents a 26.88% decrease in their position. The disclosure for this sale can be found here. Insiders sold 22,721 shares of company stock worth $1,677,017 over the last quarter. 6.40% of the stock is currently owned by company insiders.
Institutional Trading of Moelis & Company
A number of institutional investors have recently made changes to their positions in the business. Vanguard Group Inc. lifted its position in shares of Moelis & Company by 1.9% in the first quarter. Vanguard Group Inc. now owns 8,305,688 shares of the asset manager’s stock worth $484,720,000 after purchasing an additional 158,373 shares in the last quarter. Charles Schwab Investment Management Inc. lifted its position in shares of Moelis & Company by 214.5% in the first quarter. Charles Schwab Investment Management Inc. now owns 2,942,299 shares of the asset manager’s stock worth $171,713,000 after purchasing an additional 2,006,747 shares in the last quarter. Goldman Sachs Group Inc. lifted its position in shares of Moelis & Company by 32.6% in the first quarter. Goldman Sachs Group Inc. now owns 2,356,893 shares of the asset manager’s stock worth $137,548,000 after purchasing an additional 579,529 shares in the last quarter. Ameriprise Financial Inc. lifted its position in shares of Moelis & Company by 4.4% in the first quarter. Ameriprise Financial Inc. now owns 2,260,345 shares of the asset manager’s stock worth $131,914,000 after purchasing an additional 95,114 shares in the last quarter. Finally, Madison Asset Management LLC raised its position in Moelis & Company by 8.5% during the first quarter. Madison Asset Management LLC now owns 1,264,200 shares of the asset manager’s stock worth $73,779,000 after acquiring an additional 99,313 shares in the last quarter. Institutional investors own 91.53% of the company’s stock.
Moelis & Company Company Profile
Moelis & Co operates as a holding company. It engages in the provision of financial advisory, capital raising and asset management services to a client base including corporations, governments, sovereign wealth funds and financial sponsors. The firm focuses on clients including large public multinational corporations, middle market private companies, financial sponsors, entrepreneurs and governments.
Featured Articles
- Five stocks we like better than Moelis & Company
- What is the Dogs of the Dow Strategy? Overview and Examples
- Meta’s 5 Key Pillars for AI Growth—Zuckerberg’s Bold Vision
- Why Are Stock Sectors Important to Successful Investing?
- Retail Investors Are Betting Big on Rocket Lab—Should You Too?
- Stock Market Upgrades: What Are They?
- GE Aerospace: Qatar Deal Fuels Multi-Billion Dollar Growth Engine
Receive News & Ratings for Moelis & Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Moelis & Company and related companies with MarketBeat.com's FREE daily email newsletter.